Early Postoperative PhysiotherapyNeuromuscular Electrical Stimulation (NMES)TelerehabilitationStandard Postoperative Care
Early Postoperative Physiotherapy: A structured physiotherapy program including mobilization and therapeutic exercises initiated on postoperative day 1 and continued daily until discharge (5 days).
Neuromuscular Electrical Stimulation (NMES): NMES applied to the gluteus medius muscle starting on postoperative day 1, administered daily for 5 days using standard stimulation parameters to enhance muscle activation.
Telerehabilitation: A 3-week home-based exercise program supported by synchronous video-based telerehabilitation sessions conducted three times per week after discharge.
Standard Postoperative Care: Routine postoperative care including wound monitoring and general medical follow-up during hospitalization. At discharge, patients receive a home exercise brochure without supervised rehabilitation or telerehabilitation.
Study summary
This study aims to investigate the effects of an early postoperative rehabilitation program combined with neuromuscular electrical stimulation (NMES) and telerehabilitation on functional recovery in patients undergoing total hip arthroplasty (THA).
In the early postoperative period, patients commonly experience muscle weakness, impaired gait, and functional limitations that may delay recovery. Early rehabilitation has been shown to improve functional outcomes, while NMES may enhance muscle activation, particularly in hip abductor muscles. Additionally, telerehabilitation may support continuity of care following discharge by enabling supervised home-based exercise.
In this prospective study, participants will be assigned to either an intervention group receiving early physiotherapy combined with NMES and telerehabilitation, or a control group receiving standard postoperative care. Functional outcomes, gait parameters, quality of life, and muscle-related changes will be evaluated at predefined time points.
Eligibility
Sex
ALL
Min age
50 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients scheduled for unilateral total hip arthroplasty due to osteoarthritis or developmental dysplasia of the hip (DDH)
* Aged between 50 and 75 years
* Willing and able to participate in all follow-up assessments
* Able to comply with assessment procedures
* Able to meet the requirements of telerehabilitation
* Undergoing surgery with a standardized surgical protocol
Exclusion Criteria:
* Previous history of total hip arthroplasty on either side
* Planned revision total hip arthroplasty
* Severe osteoarthritis in the contralateral hip
* Presence of severe acute metabolic, neuromuscular, or cardiovascular disease
* History of active malignancy
* Presence of respiratory infection
* Concomitant orthopedic conditions (e.g., lower extremity fractures, severe hip/knee deformities, lumbar or sacroiliac dysfunction)
* Body mass index \>35
* Occurrence of postoperative complications (e.g., prosthetic infection, thromboembolic events, or conditions requiring reoperation)
Primary outcome measure(s)
Timed Up and Go (TUG) Test — Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4. Functional mobility will be assessed using the Timed Up and Go (TUG) test. The time required to stand up from a chair, walk 3 meters, turn, return, and sit down will be recorded in seconds.
10-Meter Walk Test (10MWT) — Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4 Gait speed will be assessed using the 10-Meter Walk Test. Walking speed will be recorded in meters per second (m/s).
Stair Climb Test — Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4 Functional lower extremity performance will be assessed using the Stair Climb Test. The time required to ascend and descend a standardized flight of stairs will be recorded in seconds.
Trial sites (1)
Facility
City
Region
Status
Niğde Ömer Halisdemir University, Education and Research Hospital
Niğde
Merkez
Recruiting
More Muğla Sıtkı Koçman University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.